PMID- 22653295 OWN - NLM STAT- MEDLINE DCOM- 20131017 LR - 20220330 IS - 1574-4647 (Electronic) IS - 0161-9152 (Print) IS - 0161-9152 (Linking) VI - 35 IP - 4 DP - 2013 Aug TI - Type II TGFbeta receptor modulates chondrocyte phenotype. PG - 1105-16 LID - 10.1007/s11357-012-9433-7 [doi] AB - Aging is one of the major risk factors of osteoarthritis. This pathology during which chondrocytes undergo modifications of their phenotype may result from alteration of transforming growth factor beta (TGFbeta) signaling. This study investigates the role of TGFbeta response in the process of chondrocyte dedifferentiation/redifferentiation. Dedifferentiation was induced by successive passages of human articular chondrocytes, whereas their redifferentiation was performed by three-dimensional culture in alginate. Human mesenchymal stem cells were obtained from bone marrow and differentiated into chondrocyte-like phenotype by three-dimensional culture, embedded in the same scaffold. Protein and mRNA levels were analyzed by Western blot and real-time reverse transcription PCR. Regulatory mechanism was investigated using specific inhibitors (mithramycin), mRNA silencing or decoy oligonucleotides, and expression vectors. Chondrocyte dedifferentiation interfered with TGFbeta signaling by decreasing TbetaRII mRNA and protein levels and subsequent TGFbeta response. TbetaRII ectopic expression in passaged chondrocytes permitted to increase the expression of several matrix genes, such as aggrecan or type II collagen. Redifferentiation of passaged chondrocytes permitted to restore, at least in part, TbetaRII expression and was related to differentiation of human bone marrow mesenchymal stem cells toward chondrocytes, where both specific protein 1 (Sp1) and TbetaRII mRNA levels were increased. Moreover, Sp1 manipulation by silencing or ectopic expression and pharmacologic inhibition revealed a link between expression levels of this transcriptional factor, which is crucial for constitutive expression of TbetaRII in cartilage, and TGFbeta response. Therefore, these data permit us to suggest an important role of TbetaRII expression in the maintenance of chondrocyte phenotype, which is altered with age, and bring new insights in our understanding of chondrogenesis process. FAU - Bauge, Catherine AU - Bauge C AD - EA4652 Microenvironnement Cellulaire et Pathologies (MILPAT), Universite de Caen Basse-Normandie, 14032, Caen cedex, France. catherine.bauge@unicaen.fr FAU - Duval, Elise AU - Duval E FAU - Ollitrault, David AU - Ollitrault D FAU - Girard, Nicolas AU - Girard N FAU - Leclercq, Sylvain AU - Leclercq S FAU - Galera, Philippe AU - Galera P FAU - Boumediene, Karim AU - Boumediene K LA - eng PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20120601 PL - Netherlands TA - Age (Dordr) JT - Age (Dordrecht, Netherlands) JID - 101250497 RN - 0 (RNA, Messenger) RN - 0 (Transforming Growth Factor beta2) SB - IM MH - Aged MH - Aged, 80 and over MH - Aging/*genetics/metabolism/pathology MH - Blotting, Western MH - Cartilage, Articular/*metabolism/pathology MH - Cell Differentiation/genetics MH - Cells, Cultured MH - Chondrocytes/*metabolism/pathology MH - Disease Progression MH - *Gene Expression Regulation MH - Humans MH - Middle Aged MH - Osteoarthritis, Hip/genetics/metabolism/pathology MH - Phenotype MH - RNA, Messenger/*genetics/metabolism MH - Real-Time Polymerase Chain Reaction MH - Signal Transduction/genetics MH - Transforming Growth Factor beta2/biosynthesis/*genetics PMC - PMC3705098 EDAT- 2012/06/02 06:00 MHDA- 2013/10/18 06:00 PMCR- 2014/08/01 CRDT- 2012/06/02 06:00 PHST- 2011/08/11 00:00 [received] PHST- 2012/05/15 00:00 [accepted] PHST- 2012/06/02 06:00 [entrez] PHST- 2012/06/02 06:00 [pubmed] PHST- 2013/10/18 06:00 [medline] PHST- 2014/08/01 00:00 [pmc-release] AID - 9433 [pii] AID - 10.1007/s11357-012-9433-7 [doi] PST - ppublish SO - Age (Dordr). 2013 Aug;35(4):1105-16. doi: 10.1007/s11357-012-9433-7. Epub 2012 Jun 1.